Deep hyperthermia with the HYPERcollar system combined with irradiation for advanced head and neck carcinoma - a feasibility study
PURPOSE: Radiotherapy (RT) treatment of locally-advanced and recurrent head and neck carcinoma (HNC) results in disappointing outcomes. Combination of RT with cisplatin or cetuximab improves survival but the increased toxicity and patient's comorbidity warrant the need for a less-toxic radiosensitizer. Stimulated by several randomized studies demonstrating the radio-sensitizing effect of hyperthermia, we developed the HYPERcollar. Here, we report early experience and toxicity in patients with advanced HNC.
METHODS AND MATERIALS: 119 hyperthermia treatments given to 27 patients were analyzed. Hyperthermia was applied once a week by the HYPERcollar aimed at achieving 39-43 °C in the target area, up to patients' tolerance. Pre-treatment planning was used to optimize treatment settings. When possible, invasive thermometry catheters were placed.
RESULTS: Mean power applied during the 119 hyperthermia treatments ranged from 120 to 1007 W (median 543 W). 15 (13%) hyperthermia treatments were not fully completed due to: pain allocated to hyperthermia (6/15), dyspnea from sticky saliva associated with irradiation (2/15) and unknown reasons (7/15). No severe complications or enhanced thermal or mucosal toxicities were observed. Excluding post-operative treatment, response rates after 3 months were 46% (complete) and 7% (partial).
CONCLUSION: Hyperthermia with the HYPERcollar proved to be safe and feasible with good compliance and promising outcome.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group - 34(2018), 7 vom: 01. Nov., Seite 994-1001 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Verduijn, G M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Head and neck carcinoma |
---|
Anmerkungen: |
Date Completed 14.06.2019 Date Revised 14.06.2019 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/02656736.2018.1454610 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM283943289 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM283943289 | ||
003 | DE-627 | ||
005 | 20231225042051.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/02656736.2018.1454610 |2 doi | |
028 | 5 | 2 | |a pubmed24n0946.xml |
035 | |a (DE-627)NLM283943289 | ||
035 | |a (NLM)29747544 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Verduijn, G M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Deep hyperthermia with the HYPERcollar system combined with irradiation for advanced head and neck carcinoma - a feasibility study |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.06.2019 | ||
500 | |a Date Revised 14.06.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a PURPOSE: Radiotherapy (RT) treatment of locally-advanced and recurrent head and neck carcinoma (HNC) results in disappointing outcomes. Combination of RT with cisplatin or cetuximab improves survival but the increased toxicity and patient's comorbidity warrant the need for a less-toxic radiosensitizer. Stimulated by several randomized studies demonstrating the radio-sensitizing effect of hyperthermia, we developed the HYPERcollar. Here, we report early experience and toxicity in patients with advanced HNC | ||
520 | |a METHODS AND MATERIALS: 119 hyperthermia treatments given to 27 patients were analyzed. Hyperthermia was applied once a week by the HYPERcollar aimed at achieving 39-43 °C in the target area, up to patients' tolerance. Pre-treatment planning was used to optimize treatment settings. When possible, invasive thermometry catheters were placed | ||
520 | |a RESULTS: Mean power applied during the 119 hyperthermia treatments ranged from 120 to 1007 W (median 543 W). 15 (13%) hyperthermia treatments were not fully completed due to: pain allocated to hyperthermia (6/15), dyspnea from sticky saliva associated with irradiation (2/15) and unknown reasons (7/15). No severe complications or enhanced thermal or mucosal toxicities were observed. Excluding post-operative treatment, response rates after 3 months were 46% (complete) and 7% (partial) | ||
520 | |a CONCLUSION: Hyperthermia with the HYPERcollar proved to be safe and feasible with good compliance and promising outcome | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Hyperthermia | |
650 | 4 | |a head and neck carcinoma | |
650 | 4 | |a irradiation | |
700 | 1 | |a de Wee, E M |e verfasserin |4 aut | |
700 | 1 | |a Rijnen, Z |e verfasserin |4 aut | |
700 | 1 | |a Togni, P |e verfasserin |4 aut | |
700 | 1 | |a Hardillo, J A U |e verfasserin |4 aut | |
700 | 1 | |a Ten Hove, I |e verfasserin |4 aut | |
700 | 1 | |a Franckena, M |e verfasserin |4 aut | |
700 | 1 | |a van Rhoon, G C |e verfasserin |4 aut | |
700 | 1 | |a Paulides, M M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group |d 1993 |g 34(2018), 7 vom: 01. Nov., Seite 994-1001 |w (DE-627)NLM01296445X |x 1464-5157 |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2018 |g number:7 |g day:01 |g month:11 |g pages:994-1001 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/02656736.2018.1454610 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 34 |j 2018 |e 7 |b 01 |c 11 |h 994-1001 |